Duetact

Active Ingredient(s): Glimepiride + Pioglitazone Hydrochloride
FDA Approved: * July 28, 2006
Pharm Company: * TAKEDA GLOBAL
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Duetact Overview

Glimepiride, sold under the trade name Amaryl among others, is a medication used to treat diabetes mellitus type 2.[1][2] It is less preferred than metformin.[1] Use is recommended together with diet and exercise.[1] It is taken by mouth.[1] Glimepiride takes up to three hours for maximum effect and lasts for about a day.[1] Common side effects include headache, nausea, and dizziness.[1&...

Read more Duetact Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Glimepiride

Recent Duetact Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Glimepiride + Pioglitazone Hydrochloride
  • Tablet: 2mg + 30mg, 4mg + 30mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Duetact: (2 results)

Sorted by National Drug Code
  • 64764-302 Duetact 30/2 mg Oral Tablet by Takeda Pharmaceuticals America, Inc.
  • 64764-304 Duetact 30/4 mg Oral Tablet by Takeda Pharmaceuticals America, Inc.

Drugs with one or more similar ingredients: (9 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 December 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA